Kineta Inc.
Kineta Inc.
Kineta Inc.
Close
  • about
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean
  • about
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean

[be_recent_posts_author_no_link title=”Latest News from Kineta” category_id=”4,3″ num_posts=”6″ post_offset=”0″ num_words_limit=”0″ show_date_author=”1″ show_more_link=”0″ more_link_text=”Read more” show_thumbs=”0″ remove_thumb_frame=”0″ thumb_frame_shadow=”0″ default_thumb=”0″ post_thumb_width=”100″ post_thumb_height=”80″]

Recent Kineta News

  • Kineta Announces Participation at October Investor Conferences
  • Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
  • Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression
  • Kineta to Participate in Upcoming Investor Conferences
  • Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Post placeholder image
March 4, 2017 in Biotech Industry News

A little mollusk may lead to a big discovery in helping solve the U.S. opioid epidemic

Kineta Inc 1 Like Post Comments Off on A little mollusk may lead to a big discovery in helping solve the U.S. opioid epidemic
Read More
Post placeholder image
February 22, 2017 in Biotech Industry News

Biotech startup tries unique weapon in fight against chronic pain and opioid addiction: snail venom

Kineta Inc 1 Like Post Comments Off on Biotech startup tries unique weapon in fight against chronic pain and opioid addiction: snail venom
Read More
Post placeholder image
February 22, 2017 in Biotech Industry News

Biggest Northwest angel group Keiretsu details its top Seattle-area investments

Kineta Inc 1 Like Post Comments Off on Biggest Northwest angel group Keiretsu details its top Seattle-area investments
Read More
Post placeholder image
February 21, 2017 in Biotech Industry News

Snail venom compound ‘offers chronic pain therapy

Kineta Inc 2 Like Post Comments Off on Snail venom compound ‘offers chronic pain therapy
Read More
Prev1…345Next

219 Terry Ave. N. Suite 300. Seattle, WA 98109

Sign Up for Email Alerts

219 Terry Ave. N. Suite 300. Seattle, WA 98109

  • about
  • pipeline
  • partnerships
  • investors
  • contact
Sign Up for Email Alerts

© 2023 Kineta Inc.        Privacy Policy       Terms of Use

English
English
Korean